Sanofi/Regeneron Drug Approved by FDA

Friday, July 24, 2015

Source: Reuters

The U.S. Food and Drug Administration approved a potent new cholesterol-lowering drug from Sanofi SA (SASY.PA) and Regeneron Pharmaceuticals Inc (REGN.O) on Friday but limited its approved use to patients with a hereditary form of the condition and those with cardiovascular disease.

View All News »